Haleon plc (LON:HLN)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 30.46B -16.3% |
| Revenue (ttm) | 11.03B -1.8% |
| Net Income | 1.67B +15.6% |
| EPS | 0.19 +17.8% |
| Shares Out | 8.86B |
| PE Ratio | 18.58 |
| Forward PE | 16.74 |
| Dividend | 0.07 (2.07%) |
| Ex-Dividend Date | Apr 9, 2026 |
| Volume | 14,662,054 |
| Average Volume | 23,642,794 |
| Open | 344.10 |
| Previous Close | 342.30 |
| Day's Range | 342.00 - 345.11 |
| 52-Week Range | 274.40 - 419.50 |
| Beta | 0.25 |
| RSI | 49.72 |
| Earnings Date | Jul 30, 2026 |
About Haleon
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal dr... [Read more]
Full Company ProfileFinancial Performance
In 2025, Haleon's revenue was 11.03 billion, a decrease of -1.81% compared to the previous year's 11.23 billion. Earnings were 1.67 billion, an increase of 15.60%.
Financial StatementsNews
‘For The Assist': Haleon Canada launches national campaign with Canada Soccer to celebrate the small health supports behind Canadian wellbeing
New Haleon Canada creative featuring Richie Laryea anchors integrated campaign spanning media, retail, and cross-country experiential New Haleon Canada creative featuring Richie Laryea anchors integra...
Centrum Launches Newly Reformulated Adults 50+ Complete Multivitamin with Clinically Shown Cognitive Benefits
New science-backed daily multivitamin specially formulated with essential vitamins and minerals to meet nutritional and health needs of older adults New science-backed daily multivitamin specially for...
Haleon price target lowered to 325 GBp from 350 GBp at Deutsche Bank
Deutsche Bank analyst Tom Sykes lowered the firm’s price target on Haleon (HLN) to 325 GBp from 350 GBp and keeps a Sell rating on the shares. Published first on
Haleon Earnings Call Transcript: Q1 2026
Q1 organic revenue grew 2.2%, led by strong oral health and innovation, despite weak cold and flu season and macro headwinds. Guidance for 3%-5% organic growth and high single-digit operating profit is maintained, with sequential improvement expected as North America, China, and Latin America accelerate.
Haleon Earnings Call Transcript: Q1 2026
Q1 organic revenue grew 2.2%, led by strong oral health and innovation, despite weak cold and flu season and macro headwinds. Guidance for 3%-5% organic growth and high single-digit operating profit is maintained, with sequential improvement expected as North America, China, and Latin America accelerate.
Haleon Earnings release: Q1 2026
Haleon released its Q1 2026 earnings on April 29, 2026, summarizing the period's financial results.
Haleon Slides: Q1 2026
Haleon has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 29, 2026.
Haleon Earnings release: Q1 2026
Haleon released its Q1 2026 earnings on April 29, 2026, summarizing the period's financial results.
Haleon Slides: Q1 2026
Haleon has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 29, 2026.
Sensodyne maker Haleon reports organic revenue growth sligtly below estimates
British consumer healthcare group Haleon on Wednesday reported first quarter revenue growth slightly below analyst expectations, as weakness in other international markets offset growth in Nort...
Haleon launches ‘For the Assist’ campaign
Haleon (HLN), in partnership with the U.S. Soccer Federation, launched For the Assist, a new national campaign that celebrates the essential support that makes big goals possible-both on and off
Haleon Launches For the Assist Campaign in Partnership with the U.S. Soccer Federation Featuring Stars Tyler Adams and Crystal Dunn
WARREN, N.J.--(BUSINESS WIRE)--Today, Haleon, the consumer company that is solely focused on better everyday health, in partnership with the U.S. Soccer Federation, launched For the Assist, a new nati...
Brands Like Nestlé, Haleon, and Molson Coors Wrestle With Broken Measurement
Measuring the efficacy of ad spend continues to be one of the thorniest issues marketers face, and the frustrations bubbled up across multiple sessions during ADWEEK House at the Possible conference i...
Haleon appoints Richard Manso as U.S. CMO
Haleon (HLN) announced the appointment of Richard Manso as US Chief Marketing Officer. In this role, Manso will partner closely with CEO, US & President, North America Nathalie Gerschtein and
Haleon Appoints Richard Manso as US Chief Marketing Officer to Advance Data-driven, Consumer-centric Marketing in Delivering Better Everyday Health
WARREN, N.J.--(BUSINESS WIRE)--Today Haleon (NYSE: HLN), the consumer company that is solely focused on better everyday health, announced the appointment of Richard Manso as US Chief Marketing Officer...
Haleon price target raised to 512 GBp from 510 GBp at Berenberg
Berenberg raised the firm’s price target on Haleon (HLN) to 512 GBp from 510 GBp and keeps a Buy rating on the shares.
Haleon price target raised to 440 GBp from 420 GBp at Morgan Stanley
Morgan Stanley raised the firm’s price target on Haleon (HLN) to 440 GBp from 420 GBp and keeps an Overweight rating on the shares.
NEW parodontax Gum Strengthen & Protect Launches as a Daily Solution for Long-Term Gum Protection
WARREN, N.J.--(BUSINESS WIRE)--parodontax, the gum expert brand from Haleon, has launched NEW parodontax Gum Strengthen & Protect Toothpaste and Mouthwash with Hyaluronic Acid^, a daily oral care inno...
Haleon Strengthens Commitment to China as Consumers Focus on Better Everyday Health
SHANGHAI--(BUSINESS WIRE)-- #ConsumerHealth--Haleon, a consumer company that is solely focused on better everyday health, is investing £65 million in a new state-of-the-art oral health manufacturing s...
Haleon makes oral-health push in China as other Western brands falter
Haleon is stepping up its Chinese expansion, pushing into second- and third-tier cities and tailoring its gum-health products to local tastes, aiming to succeed where many Western consumer brands hav...
Study in Nature Medicine Finds Taking Centrum Silver Daily May Slow Biological Aging
WARREN, N.J.--(BUSINESS WIRE)--A new ancillary study published in Nature Medicine shows that Centrum Silver may slow biological aging markers. The findings come from an analysis of data from a randomi...
Haleon Earnings Call Transcript: H2 2025
Organic sales grew 3% in 2025, with strong gains in oral health and emerging markets, but U.S. and cold/flu categories lagged. Gross margin rose 220 bps, and 2026 guidance targets 3%-5% growth, supported by organizational changes and increased investment in A&P and R&D.
Haleon Earnings Call Transcript: H2 2025
Organic sales grew 3% in 2025, with strong gains in oral health and emerging markets, but U.S. and cold/flu categories lagged. Gross margin rose 220 bps, and 2026 guidance targets 3%-5% growth, supported by organizational changes and increased investment in A&P and R&D.
Haleon Annual report: H2 2025
Haleon has published its H2 2025 annual report on February 25, 2026.
Haleon Annual report: H2 2025
Haleon has published its H2 2025 annual report on February 25, 2026.